NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $4,000 | -77.8% | 46,440 | -43.1% | 0.00% | – |
| Q3 2018 | $18,000 | 0.0% | 81,556 | 0.0% | 0.00% | – |
| Q2 2018 | $18,000 | -37.9% | 81,556 | 0.0% | 0.00% | – |
| Q1 2018 | $29,000 | -40.8% | 81,556 | -43.7% | 0.00% | – |
| Q4 2017 | $49,000 | -23.4% | 144,966 | -12.1% | 0.00% | -100.0% |
| Q3 2017 | $64,000 | -31.2% | 164,966 | -7.3% | 0.00% | 0.0% |
| Q2 2017 | $93,000 | -10.6% | 177,966 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $104,000 | -2.8% | 177,966 | +7.2% | 0.00% | 0.0% |
| Q4 2016 | $107,000 | -26.7% | 166,066 | +3.0% | 0.00% | -50.0% |
| Q3 2016 | $146,000 | +73.8% | 161,266 | +1.1% | 0.00% | +100.0% |
| Q2 2016 | $84,000 | -35.9% | 159,466 | +12.9% | 0.00% | – |
| Q1 2016 | $131,000 | -26.4% | 141,266 | +3.7% | 0.00% | -100.0% |
| Q4 2015 | $178,000 | -46.5% | 136,266 | -5.9% | 0.00% | -50.0% |
| Q3 2015 | $333,000 | -55.7% | 144,756 | -69.0% | 0.00% | -66.7% |
| Q2 2015 | $752,000 | +1988.9% | 467,138 | +1985.4% | 0.01% | +1100.0% |
| Q1 2015 | $36,000 | +12.5% | 22,400 | +32.5% | 0.00% | – |
| Q4 2014 | $32,000 | – | 16,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |